肿瘤学 SCIE

期刊简介估计审稿时候： 较慢,6-12周

Although laboratory and clinical cancer research need to be closely linked, observations at the basic level often remain removed from medical applications. This journal works to accelerate the translation of experimental results into the clinic, and back again into the laboratory for further investigation. The fundamental purpose of this effort is to advance clinically-relevant knowledge of cancer, and improve the outcome of prevention, diagnosis and treatment of malignant disease. The journal publishes significant clinical studies from cancer programs around the world, along with important translational laboratory findings, mini-reviews (invited and submitted) and in-depth discussions of evolving and controversial topics in the oncology arena. A unique feature of the journal is a new section which focuses on rapid peer-review and subsequent publication of short reports of phase 1 and phase 2 clinical cancer trials, with a goal of insuring that high-quality clinical cancer research quickly enters the public domain, regardless of the trial’s ultimate conclusions regarding efficacy or toxicity.

虽然尝试室和临床癌症研讨须要慎密接洽，但底子层面的察看功效常常与医学利用相距甚远。本期刊努力于加快尝试功效向临床的转化，并再次前往尝试室停止进一步研讨。这项任务的底子方针是推动与临床相干的癌症常识，并改良恶性疾病的防备、诊断和医治功效。该期刊颁发来自天下各地癌症名方针主要临床研讨，和主要的转化尝试室发明、小型批评（约请和提交）和对肿瘤学范畴不时成长和有争议的话题的深切会商。该期刊的一个怪异的地方是新开设了一个栏目，重点存眷疾速同业评审和随后颁发 1 期和 2 期临床癌症实验的冗长报告，方针是确保高品质的临床癌症研讨敏捷进入大众范畴，不管实验终究得出的疗效或毒性论断若何。

《Oncology》(肿瘤学)编辑部通信体例为KARGER, ALLSCHWILERSTRASSE 10, BASEL, SWITZERLAND, CH-4009。若是您须要辅佐投稿或润稿办事，您可以或许征询咱们的客服教员。咱们专一于期刊征询办事十年，熟习颁发政策，可为您供给一对一投稿指点，防止您在投稿时频仍碰鼻，节流您的可贵时候，有用晋升颁发机率，确保SCI检索（检索不了全额退款）。咱们视诺言为生命，多方面确保文章宁静失密，在任何环境下都不会泄漏您的小我信息或稿件内容。